BIRMINGHAM, Ala., July 29 /PRNewswire/ -- Michael Cobble, M.D., director of Canyons Medical Center in Sandy, Utah, has been appointed as Chief Medical Officer of Atherotech, Inc.
Cobble is a primary care physician, board-certified lipidologist and certified hypertension specialist. His responsibilities at the Birmingham-based cardiodiagnostic company will include educating the public and health care professionals about Atherotech's line of cardiometabolic tests. He'll also be responsible for furthering understanding and acceptance of the VAP(R) (Vertical Auto Profile) Cholesterol Test in advanced lipid testing.
Cobble succeeds James Ehrlich, M.D., who will continue to serve as a medical consultant to Atherotech while pursuing advocacy efforts for the early detection and prevention of heart disease.
"We are honored to have such a respected and passionate champion of cardiovascular health join our team," said Atherotech President and CEO Mike Mullen. "Dr. Cobble engages in clinical research and medical education to advance the understanding of cardiovascular disease, yet much of his time is spent in the real world of direct patient care and interaction. This constitutes a unique skill set that will be highly beneficial to Atherotech."
Cobble will maintain his role at Canyons Medical Center and continue to practice a full range of medicine, including diabetes care, cardiovascular disease, hypertension, dyslipidemia, and bipolar and mood disorders.
"I'm excited to join Atherotech with their dedication to lipid assessment and risk management," said Cobble. "Too many cardiovascular events continue to occur in 'low risk' as well as 'high risk' individuals, pointing to the fact that diagnostic testing and treatments need further research and focus. The VAP lipid test has been a powerful tool in our clinic and thousands of others
|SOURCE Atherotech, Inc.|
Copyright©2009 PR Newswire.
All rights reserved